On the public citation graph
NAFLD‐related hepatocellular carcinoma: The growing challenge
0 signed · 344 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.287.3.356openalex-snapshot
Prevalence of the Metabolic Syndrome Among US Adults
inferredcites →https://doi.org/10.1001/jamaoncol.2017.3055openalex-snapshot
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
inferredcites →https://doi.org/10.1001/jamaoncol.2019.2996openalex-snapshot
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
inferredcites →https://doi.org/10.1002/cncr.24982openalex-snapshot
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.28832openalex-snapshot
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS‐HCC risk model
inferredcites →https://doi.org/10.1002/dmrr.1291openalex-snapshot
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
inferredcites →https://doi.org/10.1002/hep.20554openalex-snapshot
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease†
inferredcites →https://doi.org/10.1002/hep.22142openalex-snapshot
Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat
inferredcites →https://doi.org/10.1002/hep.23527openalex-snapshot
the Incidence and Risk Factors of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.23594openalex-snapshot
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
inferredcites →https://doi.org/10.1002/hep.24397openalex-snapshot
Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database
inferredcites →https://doi.org/10.1002/hep.28123openalex-snapshot
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
inferredcites →https://doi.org/10.1002/hep.28356openalex-snapshot
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
inferredcites →https://doi.org/10.1002/hep.28431openalex-snapshot
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
inferredcites →https://doi.org/10.1002/hep.29367openalex-snapshot
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
inferredcites →https://doi.org/10.1002/hep.30036openalex-snapshot
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1002/hep.30170openalex-snapshot
Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study
inferredcites →https://doi.org/10.1002/hep.30858openalex-snapshot
Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1002/hep.31014openalex-snapshot
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1002/hep.31113openalex-snapshot
PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality
inferredcites →https://doi.org/10.1002/hep.31238openalex-snapshot
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
inferredcites →https://doi.org/10.1002/hep.31500openalex-snapshot
Hepatic Fat—Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs
inferredcites →https://doi.org/10.1002/hep.31845openalex-snapshot
Cancer Risk in Patients With Biopsy‐Confirmed Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study
inferredcites →https://doi.org/10.1002/hep.32244openalex-snapshot
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep4.1606openalex-snapshot
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/ijc.26338openalex-snapshot
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
inferredcites →https://doi.org/10.1002/ijc.30784openalex-snapshot
The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/ijc.31910openalex-snapshot
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases
inferredcites →https://doi.org/10.1002/mc.22057openalex-snapshot
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction
inferredcites →https://doi.org/10.1007/s00535-009-0085-zopenalex-snapshot
Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1007/s10620-018-5331-xopenalex-snapshot
Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades
inferredcites →https://doi.org/10.1007/s12072-010-9225-zopenalex-snapshot
Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients
inferredcites →https://doi.org/10.1007/s12072-015-9679-0openalex-snapshot
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
inferredcites →https://doi.org/10.1016/j.ccr.2012.02.007openalex-snapshot
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
inferredcites →https://doi.org/10.1016/j.cgh.2015.07.019openalex-snapshot
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.cgh.2018.05.039openalex-snapshot
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.cgh.2018.05.057openalex-snapshot
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
inferredcites →https://doi.org/10.1016/j.cgh.2019.02.007openalex-snapshot
American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults
inferredcites →https://doi.org/10.1016/j.cgh.2019.08.011openalex-snapshot
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.cgh.2019.11.012openalex-snapshot
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/j.cgh.2021.12.002openalex-snapshot
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
inferredcites →https://doi.org/10.1016/j.dld.2021.12.002openalex-snapshot
Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk
inferredcites →https://doi.org/10.1016/j.jhep.2004.01.028openalex-snapshot
Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2004.10.005openalex-snapshot
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jhep.2012.01.007openalex-snapshot
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.jhep.2013.08.011openalex-snapshot
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
inferredcites →https://doi.org/10.1016/j.jhep.2014.02.030openalex-snapshot
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jhep.2016.08.001openalex-snapshot
Management of the patient with SVR
inferredcites →https://doi.org/10.1016/j.jhep.2017.07.033openalex-snapshot
Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis
inferredcites →https://doi.org/10.1016/j.jhep.2018.06.007openalex-snapshot
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis
inferredcites →https://doi.org/10.1016/j.jhep.2019.05.008openalex-snapshot
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
inferredcites →https://doi.org/10.1016/j.jhep.2019.06.021openalex-snapshot
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.jhep.2019.11.003openalex-snapshot
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
inferredcites →https://doi.org/10.1016/j.jhep.2020.02.020openalex-snapshot
Update on NAFLD genetics: From new variants to the clinic
inferredcites →https://doi.org/10.1016/j.jhep.2020.11.024openalex-snapshot
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
inferredcites →https://doi.org/10.1016/j.jhep.2021.05.008openalex-snapshot
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.jhepr.2021.100231openalex-snapshot
NAFLD and MAFLD as emerging causes of HCC: A populational study
inferredcites →https://doi.org/10.1016/j.metop.2021.100090openalex-snapshot
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study
inferredcites →https://doi.org/10.1016/j.transproceed.2016.01.077openalex-snapshot
Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis
inferredcites →https://doi.org/10.1016/j.yexmp.2018.01.001openalex-snapshot
Genetic variants in COL13A1, ADIPOQ and SAMM50 , in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population
inferredcites →https://doi.org/10.1038/ajg.2013.476openalex-snapshot
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
inferredcites →https://doi.org/10.1038/ajg.2013.5openalex-snapshot
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1038/bjc.2014.579openalex-snapshot
Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
inferredcites →https://doi.org/10.1038/ng.257openalex-snapshot
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1038/s41575-019-0145-7openalex-snapshot
From NASH to HCC: current concepts and future challenges
inferredcites →https://doi.org/10.1038/s41575-020-00381-6openalex-snapshot
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
inferredcites →https://doi.org/10.1038/s41598-017-04991-0openalex-snapshot
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
inferredcites →https://doi.org/10.1038/s41598-019-39998-2openalex-snapshot
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1038/srep33743openalex-snapshot
Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2014.11.039openalex-snapshot
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
inferredcites →https://doi.org/10.1053/j.gastro.2015.03.044openalex-snapshot
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2015.04.043openalex-snapshot
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2018.04.034openalex-snapshot
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
inferredcites →https://doi.org/10.1053/j.gastro.2018.08.024openalex-snapshot
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2019.12.053openalex-snapshot
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review
inferredcites →https://doi.org/10.1053/j.gastro.2020.06.006openalex-snapshot
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
inferredcites →https://doi.org/10.1053/j.gastro.2021.03.021openalex-snapshot
Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity
inferredcites →https://doi.org/10.1056/nejmoa021423openalex-snapshot
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
inferredcites →https://doi.org/10.1056/nejmoa0907295openalex-snapshot
Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1056/nejmoa1712191openalex-snapshot
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
inferredcites →https://doi.org/10.1093/aje/kwt335openalex-snapshot
The 2014 Surgeon General's Report: Commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and Updating the Evidence on the Health Consequences of Cigarette Smoking
inferredcites →https://doi.org/10.1093/ije/dyaa089openalex-snapshot
Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score
inferredcites →https://doi.org/10.1097/00006254-200209000-00017openalex-snapshot
Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey
inferredcites →https://doi.org/10.1097/mcg.0000000000001260openalex-snapshot
Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1111/apt.14261openalex-snapshot
Temporal trends, clinical patterns and outcomes of NAFLD ‐related HCC in patients undergoing liver resection over a 20‐year period
inferredcites →https://doi.org/10.1111/apt.14937openalex-snapshot
Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases
inferredcites →https://doi.org/10.1111/apt.16335openalex-snapshot
Systematic review with meta‐analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/hepr.12840openalex-snapshot
Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression
inferredcites →https://doi.org/10.1111/imj.12624openalex-snapshot
Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in S outh A uckland, N ew Z ealand
inferredcites →https://doi.org/10.1111/j.1478-3231.2009.01988.xopenalex-snapshot
Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.1872-034x.2011.00883.xopenalex-snapshot
Angiotensinogen gene haplotype is associated with the prevalence of Japanese non‐alcoholic steatohepatitis
inferredcites →https://doi.org/10.1111/jebm.12270openalex-snapshot
Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies
inferredcites →https://doi.org/10.1111/jgh.14608openalex-snapshot
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis
inferredcites →https://doi.org/10.1111/jgh.14867openalex-snapshot
The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis
inferredcites →https://doi.org/10.1111/jvh.13167openalex-snapshot
Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response
inferredcites →https://doi.org/10.1111/liv.14087openalex-snapshot
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
inferredcites →https://doi.org/10.1136/gut.2008.164053openalex-snapshot
Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH
inferredcites →https://doi.org/10.1136/gut.2009.190801openalex-snapshot
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1158/0008-5472.can-06-1078openalex-snapshot
Spontaneous Development of Liver Tumors in the Absence of the Bile Acid Receptor Farnesoid X Receptor
inferredcites →https://doi.org/10.1159/000333210openalex-snapshot
Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-Endemic Area
inferredcites →https://doi.org/10.1186/s12916-019-1321-xopenalex-snapshot
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
inferredcites →https://doi.org/10.1200/jco.2018.36.15_suppl.1568openalex-snapshot
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study.
inferredcites →https://doi.org/10.1210/me.2009-0286openalex-snapshot
FXR Regulates Liver Repair after CCl4-Induced Toxic Injury
inferredcites →https://doi.org/10.1371/journal.pone.0038322openalex-snapshot
Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese
inferredcites →https://doi.org/10.1371/journal.pone.0185490openalex-snapshot
Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers
inferredcites →https://doi.org/10.1371/journal.pone.0204412openalex-snapshot
Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis
inferredcites →https://doi.org/10.14309/ajg.0000000000001347openalex-snapshot
Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis
inferredcites →https://doi.org/10.3389/fmicb.2017.01804openalex-snapshot
Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model
inferredcites →https://doi.org/10.3390/cancers13030516openalex-snapshot
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3390/jcm10153392openalex-snapshot
The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis
inferredcites →https://doi.org/10.3748/wjg.v21.i4.1189openalex-snapshot
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.3748/wjg.v24.i13.1440openalex-snapshot
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
inferredcites →https://doi.org/10.7892/boris.67130openalex-snapshot
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5114053openalex-extracted
Natural Products as Modulators of Nrf2 Signaling Pathway: Potential Therapeutic Agents for Metabolic Associated Fatty Liver Disease
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.21019openalex-snapshot
Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.1002/advs.202302953openalex-snapshot
Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
inferred← citeshttps://doi.org/10.1002/cam4.71738openalex-snapshot
Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC : Unraveling the Connection
inferred← citeshttps://doi.org/10.1002/hsr2.70551openalex-snapshot
The Effect of Nonalcoholic Fatty Liver Disease on Extrahepatic Cancers: Evidence From Population‐Based Cohort and Mendelian Randomization
inferred← citeshttps://doi.org/10.1002/jbt.23595openalex-snapshot
Cellular and molecular effects of fipronil in lipid metabolism of HepG2 and its possible connection to non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/jcla.70265openalex-snapshot
IGFBP3 As a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma: A Multi‐Cohort Analysis
inferred← citeshttps://doi.org/10.1002/mco2.724openalex-snapshot
Copper homeostasis and cuproptosis in health and disease
inferred← citeshttps://doi.org/10.1002/mnfr.202200348openalex-snapshot
MicroRNA‐29a Compromises Hepatic Adiposis and Gut Dysbiosis in High Fat Diet‐Fed Mice via Downregulating Inflammation
inferred← citeshttps://doi.org/10.1002/poh2.100openalex-snapshot
Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD)
inferred← citeshttps://doi.org/10.1002/ueg2.12524openalex-snapshot
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
inferred← citeshttps://doi.org/10.1007/978-3-031-33548-8_1openalex-snapshot
The Nomenclature and Definition of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s00125-024-06224-2openalex-snapshot
Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1
inferred← citeshttps://doi.org/10.1007/s00535-026-02473-7openalex-snapshot
Alcohol involvement may modify the association between previous hepatitis B virus infection and hepatocellular carcinoma risk in steatotic liver disease
inferred← citeshttps://doi.org/10.1007/s10120-025-01711-wopenalex-snapshot
Subtype-specific associations of steatotic liver disease with gastric and esophageal cancers: a nationwide cohort study
inferred← citeshttps://doi.org/10.1007/s11901-023-00623-6openalex-snapshot
Risk of Liver Cancer in MASLD: Role of Genetic Risk Scores
inferred← citeshttps://doi.org/10.1007/s12026-024-09585-3openalex-snapshot
Identifying potential signatures of immune cells in hepatocellular carcinoma using integrative bioinformatics approaches and machine-learning strategies
inferred← citeshttps://doi.org/10.1007/s12032-023-02091-wopenalex-snapshot
Hydrogen sulfide suppresses H2O2-induced proliferation and migration of HepG2 cells through Wnt/β-catenin signaling pathway
inferred← citeshttps://doi.org/10.1007/s12672-023-00695-2openalex-snapshot
The interplay between N6-methyladenosine and precancerous liver disease: molecular functions and mechanisms
inferred← citeshttps://doi.org/10.1007/s12672-024-01558-0openalex-snapshot
TMSB4X is a regulator of inflammation-associated ferroptosis, and promotes the proliferation, migration and invasion of hepatocellular carcinoma cells
inferred← citeshttps://doi.org/10.1007/s12672-025-02177-zopenalex-snapshot
Assessing the effect of modifiable risk factors on hepatocellular carcinoma: evidence from a bidirectional Mendelian randomization analysis
inferred← citeshttps://doi.org/10.1007/s12672-025-03399-xopenalex-snapshot
Global, regional, and National burden of metabolic dysfunction-associated steatohepatitis-related liver cancer in older adults: trends and cross-national inequality based on the global burden of disease study 2021
inferred← citeshttps://doi.org/10.1007/s13304-024-01827-1openalex-snapshot
Evolution of transplant oncology indications: a single-institution experience over 40 years
inferred← citeshttps://doi.org/10.1016/j.amjmed.2024.06.031openalex-snapshot
Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis
inferred← citeshttps://doi.org/10.1016/j.aohep.2026.102225openalex-snapshot
Challenges and adherence to hepatocellular carcinoma surveillance in patients with advanced chronic liver disease
inferred← citeshttps://doi.org/10.1016/j.bbadis.2026.168471openalex-snapshot
GPAT3 protects against lipid stress-induced ferroptosis in hepatocellular carcinoma: From multi-omics analysis to functional validation
inferred← citeshttps://doi.org/10.1016/j.bbrc.2024.149781openalex-snapshot
Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway
inferred← citeshttps://doi.org/10.1016/j.bcp.2023.115762openalex-snapshot
Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116610openalex-snapshot
Daphnetin ameliorates hepatic steatosis by suppressing peroxisome proliferator-activated receptor gamma (PPARG) in ob/ob mice
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.117892openalex-snapshot
The roles and mechanisms of sulfur metabolism and disulfidptosis in metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.117989openalex-snapshot
The therapeutic role of natural compounds mediated through Nrf2 in metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.biocel.2025.106751openalex-snapshot
Identification of a liver fibrosis and disease progression-related transcriptome signature in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2024.122635openalex-snapshot
Multifunctional fluorescence/photoacoustic bimodal imaging of γ-glutamyltranspeptidase in liver disorders under different triggering conditions
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116702openalex-snapshot
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
inferred← citeshttps://doi.org/10.1016/j.carbpol.2023.121499openalex-snapshot
High-throughput intact Glycopeptide quantification strategy with targeted-MS (HTiGQs-target) reveals site-specific IgG N-glycopeptides as biomarkers for hepatic disorder diagnosis and staging
inferred← citeshttps://doi.org/10.1016/j.cca.2024.117796openalex-snapshot
MicroRNA biosensors for the detection of liver cancer
inferred← citeshttps://doi.org/10.1016/j.cld.2024.06.007openalex-snapshot
Alcohol and Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.clinsp.2026.100882openalex-snapshot
Validation of the GALAD model for diagnosing HBV-related hepatocellular carcinoma in Chinese patients
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2025.108722openalex-snapshot
Integrative genomic and transcriptomic profiling identifies HSPA5 as a central player in hepatocellular carcinoma pathogenesis
inferred← citeshttps://doi.org/10.1016/j.dld.2024.05.010openalex-snapshot
Identification of key markers for the stages of nonalcoholic fatty liver disease: An integrated bioinformatics analysis and experimental validation
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.179008openalex-snapshot
DTMB attenuates hepatic inflammation and lipid dysregulation via PPAR-γ modulation in diet-induced steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.envint.2024.108637openalex-snapshot
Long-term exposure to ambient fine particulate matter and risk of liver cancer in the NIH-AARP Diet and Health Study
inferred← citeshttps://doi.org/10.1016/j.esmogo.2025.100284openalex-snapshot
Revisiting cholesterol metabolism in hepatocellular carcinoma: a hidden driver of systemic therapy response
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2025.03.021openalex-snapshot
Carboxylesterase 2A gene knockout or enzyme inhibition alleviates steatohepatitis in rats by regulating PPARγ and endoplasmic reticulum stress
inferred← citeshttps://doi.org/10.1016/j.genrep.2024.101964openalex-snapshot
Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.gtc.2023.03.008openalex-snapshot
The Effect of Obesity on Gastrointestinal Disease
inferred← citeshttps://doi.org/10.1016/j.hbpd.2023.06.006openalex-snapshot
Gut microbiome and nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.hbpd.2024.09.006openalex-snapshot
Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection
inferred← citeshttps://doi.org/10.1016/j.hpb.2026.06.020openalex-snapshot
From screen to scalpel: total telemedicine pathway shortens liver surgery clinic and OR wait times
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2026.153451openalex-snapshot
Folic acid/3-carboxyphenylboronic acid dual-functionalized cellulose nanocrystals as a pH-responsive nanocarrier for improved curcumin delivery against hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112821openalex-snapshot
MAFLD-related hepatocellular carcinoma: Exploring the potent combination of immunotherapy and molecular targeted therapy
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.114662openalex-snapshot
E3 ubiquitin ligase TRIM38 regulates macrophage polarization to reduce hepatic inflammation by interacting with HSPA5
inferred← citeshttps://doi.org/10.1016/j.isci.2025.113843openalex-snapshot
Molecular mechanisms mediated by liquid-liquid phase separation in chronic liver disease progression
inferred← citeshttps://doi.org/10.1016/j.jbi.2024.104626openalex-snapshot
Developing deep learning-based strategies to predict the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease from electronic health records
inferred← citeshttps://doi.org/10.1016/j.jceh.2025.103202openalex-snapshot
Genetic Analysis of Metabolic-associated Steatosis Liver Disease in a Colombian Cohort
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2023.11.014openalex-snapshot
Hepatocyte Deubiquitinating Enzyme OTUD5 Deficiency is a Key Aggravator for Metabolic Dysfunction-Associated Steatohepatitis by Disturbing Mitochondrial Homeostasis
inferred← citeshttps://doi.org/10.1016/j.jff.2026.107163openalex-snapshot
A polysaccharide from Artocarpus heterophyllus Lam. pulp ameliorates oxidative stress and lipid accumulation in HepG2 cells
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106925openalex-snapshot
Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
inferred← citeshttps://doi.org/10.1016/j.phrs.2024.107375openalex-snapshot
NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors
inferred← citeshttps://doi.org/10.1016/j.pmedr.2024.102798openalex-snapshot
Association between hemoglobin and non-alcoholic fatty liver disease (NAFLD) in United States adults: Results from NHANES 2017–2020
inferred← citeshttps://doi.org/10.1016/j.taap.2024.117185openalex-snapshot
A computational model of the crosstalk between hepatocyte fatty acid metabolism and oxidative stress highlights the key enzymes, metabolites, and detoxification pathways in the context of MASLD
inferred← citeshttps://doi.org/10.1016/j.tice.2025.103200openalex-snapshot
Molecular and cellular secrets revealed: How umbilical cord-derived mesenchymal stem cells can target hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.toxlet.2024.04.010openalex-snapshot
Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats
inferred← citeshttps://doi.org/10.1021/acs.analchem.3c05676openalex-snapshot
Promoting In Vivo NIR-II Fluorescent Imaging for Lipid in Lipid Metabolism Diseases Diagnosis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00179openalex-snapshot
Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jproteome.4c00204openalex-snapshot
Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD)
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.4c01123openalex-snapshot
Development and Evaluation of 68Ga-Labeled TMTP1-Based Cyclic Peptide Probes for Targeting Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1038/s41388-024-03056-7openalex-snapshot
TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation
inferred← citeshttps://doi.org/10.1038/s41388-025-03373-5openalex-snapshot
MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41401-025-01568-wopenalex-snapshot
TSG attenuated NAFLD and facilitated weight loss in HFD-fed mice via activating the RUNX1/FGF21 signaling axis
inferred← citeshttps://doi.org/10.1038/s41416-026-03427-9openalex-snapshot
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism
inferred← citeshttps://doi.org/10.1038/s41419-025-08348-8openalex-snapshot
Targeting MED23 inhibits hepatocellular carcinoma development by suppressing compensatory proliferation and facilitating ROS-mediated cell death
inferred← citeshttps://doi.org/10.1038/s41467-024-53002-0openalex-snapshot
CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion
inferred← citeshttps://doi.org/10.1038/s41568-022-00543-5openalex-snapshot
Acetyl-CoA metabolism in cancer
inferred← citeshttps://doi.org/10.1038/s41598-024-77416-4openalex-snapshot
A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease
inferred← citeshttps://doi.org/10.1038/s41598-025-02057-0openalex-snapshot
Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41598-025-86424-xopenalex-snapshot
BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals
inferred← citeshttps://doi.org/10.1038/s41598-025-91312-5openalex-snapshot
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
inferred← citeshttps://doi.org/10.1038/s41598-025-96158-5openalex-snapshot
Identification of pyroptosis-associated gene to predict fibrosis and reveal immune characterization in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1042/bsr20221271openalex-snapshot
Inflammatory processes involved in NASH-related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1055/a-2289-2298openalex-snapshot
Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1056/evidoa2400062openalex-snapshot
Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease
inferred← citeshttps://doi.org/10.1080/13696998.2026.2627833openalex-snapshot
Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data
inferred← citeshttps://doi.org/10.1080/1744666x.2025.2514605openalex-snapshot
Metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease: prevalence, risk factors, pathophysiological pathways and clinical consequences
inferred← citeshttps://doi.org/10.1080/17843286.2025.2466011openalex-snapshot
MASH to cirrhosis: bridging the gaps in MASLD management
inferred← citeshttps://doi.org/10.1080/26896583.2023.2293493openalex-snapshot
Cellular and molecular alterations in a human hepatocellular in vitro model of nonalcoholic fatty liver disease development and stratification
inferred← citeshttps://doi.org/10.1093/gastro/goae102openalex-snapshot
Gasdermin E mediates pyroptosis in the progression of hepatocellular carcinoma: a double-edged sword
inferred← citeshttps://doi.org/10.1096/fj.202501513rropenalex-snapshot
Exosomes Derived From Bone Marrow Macrophages of HFD ‐Fed Mice Regulating AKT / GSK Pathway in Hepatocytes via miR ‐222‐5p
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000794openalex-snapshot
Electronic decision aids enhance management of primary care patients with steatotic liver disease: Proof of concept pilot study
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000836openalex-snapshot
Chemoprevention of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/hep.0000000000000668openalex-snapshot
Benefit and harm of waiting time in liver transplantation for HCC
inferred← citeshttps://doi.org/10.1097/hep.0000000000000786openalex-snapshot
Molecular mechanisms in MASLD/MASH-related HCC
inferred← citeshttps://doi.org/10.1097/hep.0000000000000890openalex-snapshot
Alcohol-associated liver cancer
inferred← citeshttps://doi.org/10.1097/hep.0000000000000937openalex-snapshot
Effect of phospholipid curcumin Meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial
inferred← citeshttps://doi.org/10.1097/md.0000000000035740openalex-snapshot
Risk factors and prevention of liver cancer: A bibliometric and visual analysis
inferred← citeshttps://doi.org/10.1097/md.0000000000045125openalex-snapshot
Association between NAFLD and liver cancer: A two-sample Mendelian randomization study
inferred← citeshttps://doi.org/10.1109/cvpr52733.2024.01073openalex-snapshot
Prompting Vision Foundation Models for Pathology Image Analysis
inferred← citeshttps://doi.org/10.1111/apt.18286openalex-snapshot
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
inferred← citeshttps://doi.org/10.1111/apt.18478openalex-snapshot
Lubiprostone Reduces Fat Content on MRI ‐ PDFF in Patients With MASLD : A 48‐Week Randomised Controlled Trial
inferred← citeshttps://doi.org/10.1111/bph.16047openalex-snapshot
The heparan sulfate mimetic Muparfostat aggravates steatohepatitis in obese mice due to its binding affinity to lipoprotein lipase
inferred← citeshttps://doi.org/10.1111/dom.15846openalex-snapshot
Copper homeostasis and cuproptosis‐related genes: Therapeutic perspectives in non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/jfbc.14438openalex-snapshot
A critical review on anti‐fibrotic phytochemicals targeting activated hepatic stellate cells
inferred← citeshttps://doi.org/10.1111/jgh.16893openalex-snapshot
A Risk Prediction Model for Hepatocellular Carcinoma in the General Population Without Traditional Risk Factors for Liver Disease
inferred← citeshttps://doi.org/10.1111/liv.15819openalex-snapshot
A risk prediction model for hepatocellular carcinoma in non‐alcoholic fatty liver disease without cirrhosis
inferred← citeshttps://doi.org/10.1111/liv.70458openalex-snapshot
Exploring the Syndemic of Steatotic Liver Disease, Socioeconomic Inequities and Cancer Risk in the UK Biobank
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-092020openalex-snapshot
Association of occupational physical activity and sedentary behaviour with the risk of hepatocellular carcinoma: a case-control study based on the Inpatient Clinico-Occupational Database of Rosai Hospital Group
inferred← citeshttps://doi.org/10.1136/egastro-2023-100020openalex-snapshot
Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
inferred← citeshttps://doi.org/10.1136/gutjnl-2025-334981openalex-snapshot
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1155/2022/5638675openalex-snapshot
Prognostic Significance of CCDC137 Expression and Its Association with Immune Infiltration in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1155/2023/6645476openalex-snapshot
A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1155/2024/4864639openalex-snapshot
Type III Secretion System in Intestinal Pathogens and Metabolic Diseases
inferred← citeshttps://doi.org/10.11569/wcjd.v31.i10.404openalex-snapshot
Circulating biomarkers for diagnosis and management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1159/000531682openalex-snapshot
Removable Transduodenal Bypass: Development of a New Endoscopic Concept
inferred← citeshttps://doi.org/10.1159/000535943openalex-snapshot
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
inferred← citeshttps://doi.org/10.1159/000550163openalex-snapshot
The Emerging Challenge of Non-Cirrhotic MASLD-Related Hepatocellular Carcinoma: Etiology, Immunopathology, and Precision Oncology
inferred← citeshttps://doi.org/10.11603/1811-2471.2024.v.i3.14901openalex-snapshot
КЛІНІЧНИЙ ПРОФІЛЬ ПАЦІЄНТІВ ІЗ НЕАЛКОГОЛЬНОЮ ЖИРОВОЮ ХВОРОБОЮ ПЕЧІНКИ ТА ІНСУЛІНОРЕЗИСТЕНТНІСТЮ
inferred← citeshttps://doi.org/10.1166/jbn.2024.3815openalex-snapshot
Minichromosome Maintenance Complex Component 5 Modified by Mettl3 Inhibits the Proliferation of Liver Cancer by Regulating PI3K/AKT/mTOR Axis
inferred← citeshttps://doi.org/10.1177/15598276261449749openalex-snapshot
Interrelationship Between Depression, Unhealthy Behavior, and Non-Alcoholic Fatty Liver Disease in the United States of America
inferred← citeshttps://doi.org/10.1177/20406223251339402openalex-snapshot
Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort study
inferred← citeshttps://doi.org/10.1177/27683605261477729openalex-snapshot
Sanshimao Formula Improves Recurrence-Free Survival in Early and Intermediate Hepatocellular Carcinoma Patients with Cirrhosis: A Randomized Controlled Trial
inferred← citeshttps://doi.org/10.1186/s12866-024-03663-0openalex-snapshot
Gut microbiota and mycobiota change with feeding duration in mice on a high-fat and high-fructose diet
inferred← citeshttps://doi.org/10.1186/s12885-025-14344-0openalex-snapshot
A non-invasive nomogram for the prediction of poor prognosis of hepatocellular carcinoma based on the novel marker Interleukin-41
inferred← citeshttps://doi.org/10.1186/s12889-024-20161-0openalex-snapshot
Association of niacin intake and metabolic dysfunction-associated steatotic liver disease: findings from National Health and Nutrition Examination Survey
inferred← citeshttps://doi.org/10.1186/s12943-022-01706-6openalex-snapshot
Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1186/s12944-025-02750-zopenalex-snapshot
The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India
inferred← citeshttps://doi.org/10.1186/s12951-023-01942-yopenalex-snapshot
Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway
inferred← citeshttps://doi.org/10.1186/s12967-025-07454-7openalex-snapshot
EMP1 + hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma and predict prognosis
inferred← citeshttps://doi.org/10.1186/s13046-024-02967-3openalex-snapshot
PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer
inferred← citeshttps://doi.org/10.1186/s13098-025-01995-zopenalex-snapshot
The impact of semaglutide on liver outcomes in patients with or at risk of MASH: a dose and duration response meta-analysis of randomized trials
inferred← citeshttps://doi.org/10.1200/po-25-00638openalex-snapshot
Integrated Genetic Information of Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Traits Improves Hepatocellular Carcinoma Risk Stratification and Screening
inferred← citeshttps://doi.org/10.1259/bjr.20220702openalex-snapshot
Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study
inferred← citeshttps://doi.org/10.12677/acm.2025.15103004openalex-snapshot
Research Progress on Muscle, Fat and Adverse Liver Outcomes
inferred← citeshttps://doi.org/10.12677/acrem.2023.112007openalex-snapshot
Research Progress of Sirtuin2
inferred← citeshttps://doi.org/10.12775/jehs.2024.53.015openalex-snapshot
Genetic implications in patients with NAFLD
inferred← citeshttps://doi.org/10.1371/journal.pone.0338908openalex-snapshot
Burden of liver cancer resulting from different etiologies in China from 1990 to 2021 and prediction to 2031
inferred← citeshttps://doi.org/10.14366/usg.24205openalex-snapshot
Characterization of non-alcoholic fatty liver disease–related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid
inferred← citeshttps://doi.org/10.1515/biol-2025-1109openalex-snapshot
Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O -GlcNAcylation of ZEB1
inferred← citeshttps://doi.org/10.15403/jgld-4667openalex-snapshot
Transarterial Chemoembolization plus Apatinib with or without Camrelizumab for the Treatment of Advanced HBV-related Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.15666/aeer/2106_59415959openalex-snapshot
EFFECT OF BAICALIN ON THE INTESTINAL MICROBIOTA IN OBESE MICE INDUCED BY HIGH-FAT DIET
inferred← citeshttps://doi.org/10.20892/j.issn.2095-3941.2024.0048openalex-snapshot
Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.20960/nh.05441openalex-snapshot
Relationship between diabesity and elevated values of metabolic-associated steatotic liver disease risk scales in Spanish workers using body mass index and the body adiposity estimator criteria of Clínica de Navarra
inferred← citeshttps://doi.org/10.21037/hbsn-22-362openalex-snapshot
The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2367007/v1openalex-snapshot
Novel diagnostic, therapeutic, and prognostic biomarkers for nonalcoholic steatohepatitis-derived hepatocellular carcinoma: Capable to overcome the heterogeneity-specific barrier
inferred← citeshttps://doi.org/10.21203/rs.3.rs-5308727/v1openalex-snapshot
Association between neutrophil to high-density lipoprotein cholesterol ratio and risk of non-alcoholic fatty liver disease and liver fibrosis: A cross-sectional study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-9635032/v1openalex-snapshot
Promotora-delivered education to improve Metabolic Dysfunction-Associated Steatotic Liver Disease knowledge and engagement in noninvasive liver assessment in populations at risk for liver cancer: A mixed-methods study
inferred← citeshttps://doi.org/10.21272/eumj.2025;13(3):606-621openalex-snapshot
EPIGENETIC INFLUENCE OF LONG NON-CODING RNAS ON THE DEVELOPMENT OF METABOLICLY ASSOCIATED STEATOHEPATITIS
inferred← citeshttps://doi.org/10.2139/ssrn.5055661openalex-snapshot
Qing-Kai-Ling Oral Liquid Ameliorates Nonalcoholic Fatty Liver Disease Via Gut-Liver Axis And Driving Scfas to Regulate the Ampk/Cidea/Ppargc1a Signaling Pathway
inferred← citeshttps://doi.org/10.2147/ijn.s477248openalex-snapshot
A pH-Responsive Drug-Delivery System Based on Apatinib-Loaded Metal-Organic Frameworks for Ferroptosis-Targeted Synergistic Anti-Tumor Therapy
inferred← citeshttps://doi.org/10.21518/ms2025-342openalex-snapshot
Modern aspects of management of patients with metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.2169/internalmedicine.4337-24openalex-snapshot
Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3
inferred← citeshttps://doi.org/10.2174/0109298673288887240212065116openalex-snapshot
Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.2174/0118715206301453240910044913openalex-snapshot
Alterations of Krüppel-like Factor Signaling and Potential Targeted Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.22141/2224-0721.22.3.2026.1718openalex-snapshot
Epigenetic influence of long non-coding RNAs on the development of metabolic-associated steatohepatitis
inferred← citeshttps://doi.org/10.23736/s0026-4806.25.09726-5openalex-snapshot
Steatotic liver disease: what role does alcohol consumption play?
inferred← citeshttps://doi.org/10.3389/fbioe.2026.1748835openalex-snapshot
Clinical biomarkers and biosensors for early detection of metabolic dysfunction-associated steatohepatitis (MASH): a translational perspective
inferred← citeshttps://doi.org/10.3389/fendo.2024.1393859openalex-snapshot
Effect of sustained decreases in sedentary time and increases in physical activity on liver enzymes and indices in type 2 diabetes
inferred← citeshttps://doi.org/10.3389/fgene.2023.1112744openalex-snapshot
Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3389/fgstr.2024.1534431openalex-snapshot
Gut microbiome in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1455383openalex-snapshot
Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1+ macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1607374openalex-snapshot
Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy
inferred← citeshttps://doi.org/10.3389/fmed.2023.1294267openalex-snapshot
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic
inferred← citeshttps://doi.org/10.3389/fmed.2024.1410668openalex-snapshot
A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions
inferred← citeshttps://doi.org/10.3389/fmed.2024.1462513openalex-snapshot
Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis
inferred← citeshttps://doi.org/10.3389/fmed.2025.1705723openalex-snapshot
Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities
inferred← citeshttps://doi.org/10.3389/fnut.2024.1445080openalex-snapshot
Polyphenols alleviate metabolic disorders: the role of ubiquitin-proteasome system
inferred← citeshttps://doi.org/10.3389/fnut.2025.1597390openalex-snapshot
Gut microbiota and protein-to-protein ratios in NAFLD: insights from Mendelian randomization and murine studies
inferred← citeshttps://doi.org/10.3389/fnut.2025.1624440openalex-snapshot
Epidemiological transition of metabolic dysfunction-associated steatotic liver disease-related chronic liver disease and cirrhosis: a comparative study between China and the global population (1990–2021)
inferred← citeshttps://doi.org/10.3389/fnut.2025.1651357openalex-snapshot
Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050
inferred← citeshttps://doi.org/10.3389/fonc.2023.1127517openalex-snapshot
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
inferred← citeshttps://doi.org/10.3389/fonc.2025.1565692openalex-snapshot
Geographic diversity of human liver cancers mirrors global social inequalities
inferred← citeshttps://doi.org/10.3389/fonc.2025.1671301openalex-snapshot
Focal nodular hyperplasia combined with hepatocellular carcinoma with bone metastasis: a case report and literature review
inferred← citeshttps://doi.org/10.3389/fphar.2024.1464852openalex-snapshot
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
inferred← citeshttps://doi.org/10.3390/biomedicines12071624openalex-snapshot
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges
inferred← citeshttps://doi.org/10.3390/biomedicines13020425openalex-snapshot
Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling
inferred← citeshttps://doi.org/10.3390/cancers15030637openalex-snapshot
Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement
inferred← citeshttps://doi.org/10.3390/cancers15102853openalex-snapshot
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers15133367openalex-snapshot
Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
inferred← citeshttps://doi.org/10.3390/cancers15143629openalex-snapshot
Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers15164097openalex-snapshot
Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography
inferred← citeshttps://doi.org/10.3390/cancers15225458openalex-snapshot
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
inferred← citeshttps://doi.org/10.3390/cancers16061114openalex-snapshot
Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management
inferred← citeshttps://doi.org/10.3390/cancers16091739openalex-snapshot
Reappraisal of the Roles of the Sonic Hedgehog Signaling Pathway in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers16223797openalex-snapshot
A Proposal for a Simple Subclassification of Advanced Hepatocellular Carcinoma in Systemic Treatment
inferred← citeshttps://doi.org/10.3390/cancers17030392openalex-snapshot
Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches
inferred← citeshttps://doi.org/10.3390/cancers17193241openalex-snapshot
Association of TP53 with Defective Long Chain 3-Hydroxy acyl-CoA Dehydrogenase Induced Non-Cirrhotic Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers18040609openalex-snapshot
Advances in the Therapeutic Landscape of Hepatocellular Carcinoma: Current Strategies and Future Perspectives
inferred← citeshttps://doi.org/10.3390/cimb46060356openalex-snapshot
MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options
inferred← citeshttps://doi.org/10.3390/curroncol32010040openalex-snapshot
Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging
inferred← citeshttps://doi.org/10.3390/diseases13070207openalex-snapshot
Hepatocellular Carcinoma: A Comprehensive Review
inferred← citeshttps://doi.org/10.3390/genes15081098openalex-snapshot
Genotype-First Approach Identifies an Association between rs28374544/FOG2S657G and Liver Disease through Alterations in mTORC1 Signaling
inferred← citeshttps://doi.org/10.3390/ijms25020919openalex-snapshot
Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data
inferred← citeshttps://doi.org/10.3390/ijms25042194openalex-snapshot
Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/ijms25169074openalex-snapshot
DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application
inferred← citeshttps://doi.org/10.3390/ijms26178442openalex-snapshot
A Plant-Based Strategy for MASLD: Desmodium caudatum (Thunb.) DC. Extract Reduces Hepatic Lipid Accumulation and Improves Glycogen Storage In Vitro and In Vivo
inferred← citeshttps://doi.org/10.3390/ijms27010468openalex-snapshot
Gut Microbiota-Derived Propionic Acid Mediates ApoA-I-Induced Amelioration of MASLD via Activation of GPR43–Ca2+–CAMKII–ATGL Hepatic Lipolysis
inferred← citeshttps://doi.org/10.3390/jcm13164657openalex-snapshot
MASLD-Related Hepatocarcinoma: Special Features and Challenges
inferred← citeshttps://doi.org/10.3390/livers6050102openalex-snapshot
Current Trends in the Novel Serological Protein and Blood-Based Biomarkers for Early Detection and Prognostic Prediction of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/medicina61091711openalex-snapshot
Association Between Depression and Hepatic Steatosis According to Obese Status: The Korean National Health and Nutrition Examination Survey 2010–2019
inferred← citeshttps://doi.org/10.3390/microorganisms14040853openalex-snapshot
Mechanisms and Management Strategies of Hepatocarcinogenesis Driven by Chronic Hepatitis B Comorbid with Type 2 Diabetes
showing the first 200 of 230 · page through all 230
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.